搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Yersinia pestis bv. Antiqua UPF0401 protein yubL (yubL) CSB-YP623471YAF
CSB-EP623471YAF
CSB-BP623471YAF
CSB-MP623471YAF
CSB-EP623471YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua ATP synthase subunit alpha (atpA), partial CSB-YP623472YAF
CSB-EP623472YAF
CSB-BP623472YAF
CSB-MP623472YAF
CSB-EP623472YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua tRNA modification GTPase MnmE (mnmE) CSB-YP623473YAF
CSB-EP623473YAF
CSB-BP623473YAF
CSB-MP623473YAF
CSB-EP623473YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Urocanate hydratase (hutU), partial CSB-YP623474YAF
CSB-EP623474YAF
CSB-BP623474YAF
CSB-MP623474YAF
CSB-EP623474YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Bis (5'-nucleosyl)-tetraphosphatase, symmetrical (apaH) CSB-YP623475YAF
CSB-EP623475YAF
CSB-BP623475YAF
CSB-MP623475YAF
CSB-EP623475YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Homoserine kinase (thrB) CSB-YP623476YAF
CSB-EP623476YAF
CSB-BP623476YAF
CSB-MP623476YAF
CSB-EP623476YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Glycerol-3-phosphate acyltransferase (plsB), partial CSB-YP623477YAF
CSB-EP623477YAF
CSB-BP623477YAF
CSB-MP623477YAF
CSB-EP623477YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua LexA repressor (lexA) CSB-YP623478YAF
CSB-EP623478YAF
CSB-BP623478YAF
CSB-MP623478YAF
CSB-EP623478YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 10 kDa chaperonin (groS) CSB-YP623479YAF
CSB-EP623479YAF
CSB-BP623479YAF
CSB-MP623479YAF
CSB-EP623479YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP623480YAF
CSB-EP623480YAF
CSB-BP623480YAF
CSB-MP623480YAF
CSB-EP623480YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Protein hfq (hfq) CSB-YP623481YAF
CSB-EP623481YAF
CSB-BP623481YAF
CSB-MP623481YAF
CSB-EP623481YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Autoinducer 2 import system permease protein lsrD (lsrD), partial CSB-YP623482YAF
CSB-EP623482YAF
CSB-BP623482YAF
CSB-MP623482YAF
CSB-EP623482YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Ribose import ATP-binding protein RbsA (rbsA), partial CSB-YP623483YAF
CSB-EP623483YAF
CSB-BP623483YAF
CSB-MP623483YAF
CSB-EP623483YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP623484YAF
CSB-EP623484YAF
CSB-BP623484YAF
CSB-MP623484YAF
CSB-EP623484YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Maf-like protein YPA_3681 (YPA_3681) CSB-YP623485YAF
CSB-EP623485YAF
CSB-BP623485YAF
CSB-MP623485YAF
CSB-EP623485YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 50S ribosomal protein L11 (rplK) CSB-YP623486YAF
CSB-EP623486YAF
CSB-BP623486YAF
CSB-MP623486YAF
CSB-EP623486YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Thiazole synthase (thiG) CSB-YP623487YAF
CSB-EP623487YAF
CSB-BP623487YAF
CSB-MP623487YAF
CSB-EP623487YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua NADH pyrophosphatase (nudC) CSB-YP623488YAF
CSB-EP623488YAF
CSB-BP623488YAF
CSB-MP623488YAF
CSB-EP623488YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua HTH-type transcriptional regulator sgrR (sgrR), partial CSB-YP623489YAF
CSB-EP623489YAF
CSB-BP623489YAF
CSB-MP623489YAF
CSB-EP623489YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Secretion monitor (secM) CSB-YP623490YAF
CSB-EP623490YAF
CSB-BP623490YAF
CSB-MP623490YAF
CSB-EP623490YAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>